Efficacy and Safety of LXI-15028 Comparing With Lansoprazole in the Treatment of Duodenal Ulcer

NCT05010954 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Duodenal Ulcer

Interventions

DRUG: LXI-15028 50mg group
DRUG: Lansoprazole 30mg group

Sponsor

Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.